KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Minority Interest (2016 - 2020)

Evolent Health (EVH) has 6 years of Minority Interest data on record, last reported at $24.9 million in Q3 2020.

  • For Q3 2020, Minority Interest rose 56.89% year-over-year to $24.9 million; the TTM value through Sep 2020 reached $24.9 million, up 56.89%, while the annual FY2019 figure was $6.7 million, N/A changed from the prior year.
  • Minority Interest reached $24.9 million in Q3 2020 per EVH's latest filing, up from $6.7 million in the prior quarter.
  • Across five years, Minority Interest topped out at $234.0 million in Q1 2016 and bottomed at $6.7 million in Q4 2019.
  • Average Minority Interest over 5 years is $79.3 million, with a median of $35.1 million recorded in 2017.
  • Peak YoY movement for Minority Interest: plummeted 91.95% in 2018, then skyrocketed 325.59% in 2019.
  • A 5-year view of Minority Interest shows it stood at $209.6 million in 2016, then crashed by 83.1% to $35.4 million in 2017, then crashed by 71.75% to $10.0 million in 2018, then tumbled by 33.16% to $6.7 million in 2019, then skyrocketed by 272.66% to $24.9 million in 2020.
  • Per Business Quant database, its latest 3 readings for Minority Interest were $24.9 million in Q3 2020, $6.7 million in Q4 2019, and $15.9 million in Q3 2019.